Literature DB >> 27704372

Active Surveillance for DCIS: The Importance of Selection Criteria and Monitoring.

Lars J Grimm1, E Shelley Hwang2.   

Abstract

Mesh：

Year:  2016        PMID： 27704372     DOI： 10.1245/s10434-016-5596-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  5 in total

Review 1.  Diagnosis of ductal carcinoma in situ in an era of de-escalation of therapy.

Authors:  Stuart J Schnitt
Journal:  Mod Pathol       Date:  2020-09-09       Impact factor: 7.842

2.  Factors Associated With Underestimation of Invasive Cancer in Patients With Ductal Carcinoma In Situ: Precautions for Active Surveillance.

Authors:  Carlos Chavez de Paz Villanueva; Valentina Bonev; Maheswari Senthil; Naveenraj Solomon; Mark E Reeves; Carlos A Garberoglio; Jukes P Namm; Sharon S Lum
Journal:  JAMA Surg       Date:  2017-11-01       Impact factor: 14.766

3.  Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?

Authors:  Tawakalitu O Oseni; Barbara L Smith; Constance D Lehman; Charmi A Vijapura; Niveditha Pinnamaneni; Manisha Bahl
Journal:  Ann Surg Oncol       Date:  2020-05-16       Impact factor: 5.344

4.  A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers.

Authors:  Claudia J C Meurs; Joost van Rosmalen; Marian B E Menke-Pluijmers; Bert P M Ter Braak; Linda de Munck; Sabine Siesling; Pieter J Westenend
Journal:  Br J Cancer       Date:  2018-10-17       Impact factor: 7.640

5.  Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer.

Authors:  William H Ward; Lyudmila DeMora; Elizabeth Handorf; Elin R Sigurdson; Eric A Ross; John M Daly; Allison A Aggon; Richard J Bleicher
Journal:  Ann Surg Oncol       Date:  2019-09-27       Impact factor: 5.344
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.